Table 4.
Cox proportional hazard model for the primary end point in IgA nephropathy patients.
| Risk factor | Univariable | Multivariable | ||
|---|---|---|---|---|
| HR (95% CI) | p-value | HR (95% CI) | p-value | |
| Gender | ||||
| Male | 0.56 (0.34–0.93) | 0.025 | 1.36 (0.62–2.98) | 0.445 |
| Female | 1 (Referent) | |||
| Hypertension | 3.96 (2.39–6.56) | <0.001 | 1.99 (1.16–3.42) | 0.012 |
| Urinary protein | 1.05 (0.98–1.13) | 0.192 | 1.08 (0.98–1.18) | 0.109 |
| Serum creatinine | 1.03 (1.02–1.04) | <0.001 | 1.02 (1.00–1.05) | 0.024 |
| eGFR | 0.96 (0.95–0.97) | <0.001 | 1.00 (0.99–1.01) | 0.943 |
| CKD 1 | 1 (Referent) | |||
| CKD 2 | 4.96 (2.41–10.21) | <0.001 | 1.62 (0.64–4.11) | 0.309 |
| CKD3a | 9.71 (4.66–20.24) | <0.001 | 0.80 (0.20–3.26) | 0.759 |
| M1 | 6.14 (1.50–25.16) | 0.012 | 3.19 (0.75–13.52) | 0.116 |
| E1 | 2.33 (1.00–5.41) | 0.051 | 3.10 (1.14–8.42) | 0.027 |
| S1 | 2.32 (1.36–3.94) | 0.002 | 1.51 (0.86–2.65) | 0.155 |
| T1/T2 | 8.87 (5.30–14.83) | <0.001 | 3.34 (1.98–6.33) | <0.001 |
| C1/C2 | 1.41 (0.82–2.41) | 0.213 | 0.81 (0.43–1.53) | 0.521 |
| Age | 0.996 (0.97–1.02) | 0.781 | ||
| Serum albumin | 0.99 (0.96–1.02) | 0.507 | ||
| NS | 1.00 (0.55–1.85) | 0.991 | ||
HR, hazard ratio; 95% CI, 95% confidence interval; eGFR, estimated glomerular filtration rate; CKD, chronic kidney disease; M, mesangial proliferation; E, endocapillary proliferation; S, segmental sclerosis; T, tubular atrophy/interstitial fibrosis; C, crescents.